This finding may in part explain the distinct pattern of breast cancer phenotypes in women with LFS, with data showing that 84% of invasive tumours were hormone-responsive (ER and/or PR), with a majority of these also being positive for Her2/neu, figures which are higher than for the non-LFS population [43]. This evidence concerns the gene ERBB2 and breast cancer.